Shi Ming Ke Li is a exclusive formula of TCM, manufactured and marketed by Wansheng Pharmaceutical,which we acquired in July,2015,indicated for the treatment of Type 2 diabetic retinopathy.It is first approved by CFDA as one of the national protected TCM in 2013.